BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

541 related articles for article (PubMed ID: 11943725)

  • 1. Vascular endothelial growth factor ligands and receptors that regulate human cytotrophoblast survival are dysregulated in severe preeclampsia and hemolysis, elevated liver enzymes, and low platelets syndrome.
    Zhou Y; McMaster M; Woo K; Janatpour M; Perry J; Karpanen T; Alitalo K; Damsky C; Fisher SJ
    Am J Pathol; 2002 Apr; 160(4):1405-23. PubMed ID: 11943725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Why is placentation abnormal in preeclampsia?
    Fisher SJ
    Am J Obstet Gynecol; 2015 Oct; 213(4 Suppl):S115-22. PubMed ID: 26428489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypoxia down-regulates placenta growth factor, whereas fetal growth restriction up-regulates placenta growth factor expression: molecular evidence for "placental hyperoxia" in intrauterine growth restriction.
    Khaliq A; Dunk C; Jiang J; Shams M; Li XF; Acevedo C; Weich H; Whittle M; Ahmed A
    Lab Invest; 1999 Feb; 79(2):151-70. PubMed ID: 10068204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vascular endothelial growth factor, placenta growth factor and their receptors in isolated human trophoblast.
    Shore VH; Wang TH; Wang CL; Torry RJ; Caudle MR; Torry DS
    Placenta; 1997 Nov; 18(8):657-65. PubMed ID: 9364601
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytotrophoblasts up-regulate soluble fms-like tyrosine kinase-1 expression under reduced oxygen: an implication for the placental vascular development and the pathophysiology of preeclampsia.
    Nagamatsu T; Fujii T; Kusumi M; Zou L; Yamashita T; Osuga Y; Momoeda M; Kozuma S; Taketani Y
    Endocrinology; 2004 Nov; 145(11):4838-45. PubMed ID: 15284201
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical localization of vascular endothelial growth factor (VEGF) and its two specific receptors, Flt-1 and KDR, in the porcine placenta and non-pregnant uterus.
    Winther H; Ahmed A; Dantzer V
    Placenta; 1999 Jan; 20(1):35-43. PubMed ID: 9950143
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Upregulation of vascular endothelial growth factor (VEGF) and downregulation of placenta growth factor (PlGF) associated with malignancy in human thyroid tumors and cell lines.
    Viglietto G; Maglione D; Rambaldi M; Cerutti J; Romano A; Trapasso F; Fedele M; Ippolito P; Chiappetta G; Botti G
    Oncogene; 1995 Oct; 11(8):1569-79. PubMed ID: 7478581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel vascular endothelial growth factor encoded by Orf virus, VEGF-E, mediates angiogenesis via signalling through VEGFR-2 (KDR) but not VEGFR-1 (Flt-1) receptor tyrosine kinases.
    Meyer M; Clauss M; Lepple-Wienhues A; Waltenberger J; Augustin HG; Ziche M; Lanz C; Büttner M; Rziha HJ; Dehio C
    EMBO J; 1999 Jan; 18(2):363-74. PubMed ID: 9889193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of the soluble vascular endothelial growth factor receptor in preeclamptic patients: pathophysiological consequences.
    Tsatsaris V; Goffin F; Munaut C; Brichant JF; Pignon MR; Noel A; Schaaps JP; Cabrol D; Frankenne F; Foidart JM
    J Clin Endocrinol Metab; 2003 Nov; 88(11):5555-63. PubMed ID: 14602804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Up-regulation of flk-1/vascular endothelial growth factor receptor 2 by its ligand in a cerebral slice culture system.
    Kremer C; Breier G; Risau W; Plate KH
    Cancer Res; 1997 Sep; 57(17):3852-9. PubMed ID: 9288799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of VEGF 121 in immortalized endothelial cells causes conversion to slowly growing angiosarcoma and high level expression of the VEGF receptors VEGFR-1 and VEGFR-2 in vivo.
    Arbiser JL; Larsson H; Claesson-Welsh L; Bai X; LaMontagne K; Weiss SW; Soker S; Flynn E; Brown LF
    Am J Pathol; 2000 Apr; 156(4):1469-76. PubMed ID: 10751370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of placental vascular endothelial growth factor (VEGF) and placenta growth factor (PIGF) and soluble Flt-1 by oxygen--a review.
    Ahmed A; Dunk C; Ahmad S; Khaliq A
    Placenta; 2000; 21 Suppl A():S16-24. PubMed ID: 10831117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. VEGF, its receptors and the tie receptors in recurrent miscarriage.
    Vuorela P; Carpén O; Tulppala M; Halmesmäki E
    Mol Hum Reprod; 2000 Mar; 6(3):276-82. PubMed ID: 10694277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular biology of the VEGF and the VEGF receptor family.
    Clauss M
    Semin Thromb Hemost; 2000; 26(5):561-9. PubMed ID: 11129413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Placental expression of VEGF, PlGF and their receptors in a model of placental insufficiency-intrauterine growth restriction (PI-IUGR).
    Regnault TR; Orbus RJ; de Vrijer B; Davidsen ML; Galan HL; Wilkening RB; Anthony RV
    Placenta; 2002; 23(2-3):132-44. PubMed ID: 11945079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of vascular endothelial growth factor and vascular endothelial growth factor receptor-2 (KDR/Flk-1) in ischemic skeletal muscle and its regeneration.
    Rissanen TT; Vajanto I; Hiltunen MO; Rutanen J; Kettunen MI; Niemi M; Leppänen P; Turunen MP; Markkanen JE; Arve K; Alhava E; Kauppinen RA; Ylä-Herttuala S
    Am J Pathol; 2002 Apr; 160(4):1393-403. PubMed ID: 11943724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. VEGF regulates haematopoietic stem cell survival by an internal autocrine loop mechanism.
    Gerber HP; Malik AK; Solar GP; Sherman D; Liang XH; Meng G; Hong K; Marsters JC; Ferrara N
    Nature; 2002 Jun; 417(6892):954-8. PubMed ID: 12087404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Colocalisation of vascular endothelial growth factor and its Flt-1 receptor in human placenta.
    Ahmed A; Li XF; Dunk C; Whittle MJ; Rushton DI; Rollason T
    Growth Factors; 1995; 12(3):235-43. PubMed ID: 8619929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vascular endothelial growth factor and its receptors in control and diabetic rat eyes.
    Gilbert RE; Vranes D; Berka JL; Kelly DJ; Cox A; Wu LL; Stacker SA; Cooper ME
    Lab Invest; 1998 Aug; 78(8):1017-27. PubMed ID: 9714188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complete inhibition of vascular endothelial growth factor (VEGF) activities with a bifunctional diabody directed against both VEGF kinase receptors, fms-like tyrosine kinase receptor and kinase insert domain-containing receptor.
    Lu D; Jimenez X; Zhang H; Wu Y; Bohlen P; Witte L; Zhu Z
    Cancer Res; 2001 Oct; 61(19):7002-8. PubMed ID: 11585724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.